Header

Thyroid Cancer Clinical Trials

Category:Adult
Status:Active

Displaying 1 trial

A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)

The primary purpose of the study is to evaluate objective response rate ([ORR]: complete response [CR] and partial response [PR]) by investigator review in participants with anaplastic thyroid canc...

Diagnosis: Head and Neck Cancer, Thyroid Cancer

Phase:

Protocol Number: 16-200

'